Methyl 2-(1-methyl-1H-pyrazol-4-yl)acetate, 95.0%, 1g

Di-mu-hydroxo-bis[(N,N,N',N'-tetramethylethylenediamine)copper(II)] Chloride>97.0%(T)25g

4-Chlorobenzylsulfonamide, 97.0%, 5g

6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,3]dioxolo[4,5-b]pyridine, 95.0%, 50mg

3-Acetoxybenzoic acid, 95.0%, 1g

4-(Trifluoromethyl)salicylic acid, 98.0%, 100g

3-Amino-6-chloropyridine-2-carboxylic acid, 95.0%, 100mg

N,N'-Dimethylcyclohexane-1,2-diamine, 95.0%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(((benzyloxy)carbonyl)amino)butanoic acid, 97%, 250mg

Methylisonicotinate-N-oxide, 97.0%, 1g

5-Methyl-isoxazole-4-carboxylic acid amide, 95.0%, 250mg

Solution de réglage ICP-MS, ROTI®Star, 5 éléments dans 2% HNO3 - 10 mg/l

10,15-Dihydro-5H-diindolo[3,2-a:3',2'-c]carbazole, 95.0%, 1g